Infections in the immunocompromised host.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D001424:Bacterial Infections / Q000276:immunology; D001803:Blood Transfusion; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000276:immunology; D017053:Infection Control; D007239:Infections / Q000209:etiology* / Q000276:immunology; D009181:Mycoses / Q000276:immunology; D010585:Phagocyte Bactericidal Dysfunction / Q000276:immunology; D011528:Protozoan Infections / Q000276:immunology; D014612:Vaccines; D014777:Virus Diseases / Q000276:immunology
D000900:Anti-Bacterial Agents; D014612:Vaccines